Online citations, reference lists, and bibliographies.
← Back to Search

Cell "vision": Complementary Factor Of Protein Corona In Nanotoxicology.

M. Mahmoudi, S. N. Saeedi-Eslami, M. Shokrgozar, K. Azadmanesh, M. Hassanlou, H. Kalhor, C. Burtea, B. Rothen-Rutishauser, S. Laurent, S. Sheibani, H. Vali
Published 2012 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Engineered nanoparticles are increasingly being considered for use as biosensors, imaging agents and drug delivery vehicles. Their versatility in design and applications make them an attractive proposition for new biological and biomedical approaches. Despite the remarkable speed of development in nanoscience, relatively little is known about the interaction of nanoscale objects with living systems. In a biological fluid, proteins associate with nanoparticles, and the amount and the presentation of the proteins on their surface could lead to a different in vivo response than an uncoated particle. Here, in addition to protein adsorption, we are going to introduce concept of cell "vision", which would be recognized as another crucial factor that should be considered for the safe design of any type of nanoparticles that will be used in specific biomedical applications. The impact of exactly the same nanoparticles on various cells is significantly different and could not be assumed for other cells; the possible mechanisms that justify this cellular response relate to the numerous detoxification strategies that any particular cell can utilize in response to nanoparticles. The uptake and defence mechanism could be considerably different according to the cell type. Thus, what the cell "sees", when it is faced with nanoparticles, is most likely dependent on the cell type.
This paper references
10.1073/pnas.0608582104
Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
T. Cedervall (2007)
10.1021/cn100100e
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis.
M. Mahmoudi (2011)
10.1073/pnas.0701250104
Nucleation of protein fibrillation by nanoparticles
S. Linse (2007)
10.1021/nn300042m
Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat.
M. Mahmoudi (2012)
10.1021/ES062726M
Assessing the risks of manufactured nanomaterials.
M. Wiesner (2006)
10.1021/nn2021088
Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.
M. Mahmoudi (2011)
10.1002/smll.200700595
Cytotoxicity of nanoparticles.
Nastassja Lewinski (2008)
10.1021/cr100440g
Protein-nanoparticle interactions: opportunities and challenges.
M. Mahmoudi (2011)
10.1021/la201652h
Water-soluble iron oxide nanoparticles with high stability and selective surface functionality.
Yaolin Xu (2011)
10.1038/NMAT1251
Ultra-large-scale syntheses of monodisperse nanocrystals
J. Park (2004)
10.1046/j.1471-4159.2000.0742209.x
Charge Alterations of E22 Enhance the Pathogenic Properties of the Amyloid β‐Protein
J. Melchor (2000)
10.1016/S0169-4332(97)00234-1
Silanation and stability of 3-aminopropyl triethoxy silane on nanosized superparamagnetic particles: I. Direct silanation
Z. Xu (1997)
10.1002/ADMA.200600222
Porous, Hollow, and Ball-in-Ball Metal Oxide Microspheres: Preparation, Endocytosis, and Cytotoxicity**
W. Suh (2006)
10.1021/cr2002596
Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2012)
10.1289/ehp.8284
A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors
R. Hardman (2006)
10.1038/nnano.2007.223
Immunological properties of engineered nanomaterials
M. Dobrovolskaia (2007)
10.1002/cmmi.282
Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes.
S. Soenen (2009)
10.1002/anie.201001037
Nanotoxicology: an interdisciplinary challenge.
H. Krug (2011)
10.1016/j.actbio.2012.03.002
Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci.
G. Subbiahdoss (2012)
10.1016/j.cell.2008.11.006
Polarity and Differential Inheritance—Universal Attributes of Life?
I. Macara (2008)
10.1016/J.NANTOD.2010.01.003
Can cells reduce nanoparticle toxicity
H. Summers (2010)
10.1016/j.colsurfb.2009.08.044
A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2010)
10.1038/nnano.2008.426
Nanotoxicology: nanoparticles reconstruct lipids.
K. Dawson (2009)
10.1039/c1cs15188f
Toxicity of nanomaterials.
S. Sharifi (2012)
10.1038/nnano.2011.191
Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population.
Jong Ah Kim (2011)
10.1021/JP2056255
Large Protein Absorptions from Small Changes on the Surface of Nanoparticles
M. Mahmoudi (2011)
10.1038/nnano.2009.248
Protein-nanoparticle interactions: What does the cell see?
I. Lynch (2009)
10.1080/10590500802708267
Toxicity and Environmental Risks of Nanomaterials: Challenges and Future Needs
P. Ray (2009)
10.1039/C2RA01374F
Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease
Sophie Laurent (2012)
10.2217/nnm.09.40
The status of in vitro toxicity studies in the risk assessment of nanomaterials.
M. Park (2009)
10.1016/S1748-0132(08)70015-X
The toxicological impact of nanoparticles
R. Brayner (2008)
10.1371/journal.pone.0029997
Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and “Cell Vision”
S. Laurent (2012)
10.3402/nano.v1i0.5358
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
N. Singh (2010)
10.1016/j.addr.2009.11.008
Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
B. Fadeel (2010)
10.1073/pnas.0910757106
Modulation of γ-secretase specificity using small molecule allosteric inhibitors
C. Shelton (2009)
10.2217/nnm.10.106
Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects.
Stefaan J.H. Soenen (2010)
10.1002/jcb.1158
Oxidative stress signalling in the apoptosis of Jurkat T‐lymphocytes
R. Chiaramonte (2001)
10.1021/cr1001832
Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine.
M. Mahmoudi (2011)
10.1002/ANGE.200700465
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles.
T. Cedervall (2007)
10.1016/j.biomaterials.2008.09.050
The influence of protein adsorption on nanoparticle association with cultured endothelial cells.
Morton Ehrenberg (2009)
10.1038/nmat2442
Understanding biophysicochemical interactions at the nano-bio interface.
A. Nel (2009)
10.1038/NNANO.2010.267
Nanobiotechnology: Nanoparticle coronas take shape
M. Monopoli (2011)
10.1021/cr1003166
Effect of nanoparticles on the cell life cycle.
M. Mahmoudi (2011)
10.1016/j.addr.2010.05.006
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
10.32725/JAB.2009.008
GOLD AND NANO-GOLD IN MEDICINE: OVERVIEW, TOXICOLOGY AND PERSPECTIVES
N. R. Panyala (2009)



This paper is referenced by
10.1007/s12272-013-0292-2
Protein corona on magnetite nanoparticles and internalization of nanoparticle–protein complexes into healthy and cancer cells
W. Jiang (2014)
10.1016/j.jcis.2013.07.004
Biomimetic mucin modified PLGA nanoparticles for enhanced blood compatibility.
Y. M. Thasneem (2013)
10.1142/9789813140455_0002
Protein Binding Case Study 1: Understanding Relationship between Protein Corona and Nanoparticle Toxicity
Marina A Dobrovolskaia (2016)
10.1021/JP5075048
Impact of Surface Functionalization of AgNPs on Binding and Conformational Change of Hemoglobin (Hb) and Hemolytic Behavior
L. B. Devi (2014)
10.1039/c4nr06892k
Nanoparticle-lipid bilayer interactions studied with lipid bilayer arrays.
B.-W. Lu (2015)
10.1039/c3nr33193h
Protein fibrillation and nanoparticle interactions: opportunities and challenges.
M. Mahmoudi (2013)
The role of adsorbed proteins in the internalization of polymeric nanoparticles
L. Tavares (2016)
10.1186/s11671-016-1243-x
Imaging of Biological Cells Using Luminescent Silver Nanoparticles
V. Kravets (2016)
10.1039/c3nr32551b
Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles.
M. Mahmoudi (2013)
10.1016/j.nano.2014.11.003
Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines.
G. Caracciolo (2015)
10.1021/cr400341h
Safe Clinical Use of Carbon Nanotubes as Innovative Biomaterials
N. Saito (2014)
10.2217/nnm.15.130
Nanotoxicology: advances and pitfalls in research methodology.
M. Azhdarzadeh (2015)
10.4172/2161-0398.1000139
The Impact of the Physiochemical Properties of Manufactured Nanoparticles on In vitro and In vivo Evaluation of Particle Toxicity
Masanori Horie (2014)
10.1007/978-1-4614-9044-9_5
Particulate Exposure and Cardiovascular Inflammation
C. Wingard (2013)
10.1016/j.nano.2016.08.019
Manipulation of lipoplex concentration at the cell surface boosts transfection efficiency in hard-to-transfect cells.
S. Palchetti (2017)
10.1016/j.biocel.2015.09.002
Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients.
V. Colapicchioni (2016)
10.1002/em.22323
Evaluation of cytotoxicity and genotoxicity induced by oleic acid‐coated iron oxide nanoparticles in human astrocytes
Natalia Fernández-Bertólez (2019)
10.1039/C7TB00344G
Amino acid-modified chitosan nanoparticles for Cu2+ chelation to suppress CuO nanoparticle cytotoxicity.
Yixian Zhang (2017)
10.1039/C3BM60050E
Uptake of poly(2-hydroxypropylmethacrylamide)-coated gold nanoparticles in microvascular endothelial cells and transport across the blood-brain barrier.
C. Freese (2013)
10.1016/J.MATTOD.2013.03.005
Small fluorescent nanoparticles at the nano–bio interface
L. Shang (2013)
10.1007/s10565-017-9403-z
Exposure to silver nanoparticles affects viability and function of natural killer cells, mostly via the release of ions
L. Müller (2017)
10.1039/C2RA22093H
Plasma concentration gradient influences the protein corona decoration on nanoparticles
Mahdi Ghavami (2013)
10.1016/j.tibtech.2018.02.014
Debugging Nano-Bio Interfaces: Systematic Strategies to Accelerate Clinical Translation of Nanotechnologies.
M. Mahmoudi (2018)
10.3390/nano10071374
Cellular Responses of Human Lymphatic Endothelial Cells to Carbon Nanomaterials
Mahoko Sano (2020)
10.1002/cmmi.1638
Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.
S. Sharifi (2015)
10.1016/j.biomaterials.2019.119704
Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson's disease: From preclinical to translational studies.
Govindarajan Karthivashan (2019)
10.1016/j.bbagen.2016.05.007
Enlightening mineral iron sensing in Pseudomonas fluorescens by surface active maghemite nanoparticles: Involvement of the OprF porin.
M. Magro (2016)
10.1002/jat.3385
Comparative genotoxicity of silver nanoparticles in human liver HepG2 and lung epithelial A549 cells
J. Wang (2017)
10.1021/nn305337c
Temperature: the "ignored" factor at the NanoBio interface.
M. Mahmoudi (2013)
10.2217/nnm.15.159
Nanomedical innovation: the SEON-concept for an improved cancer therapy with magnetic nanoparticles.
S. Lyer (2015)
10.2217/nnm-2017-0178
Plasma protein adsorption and biological identity of systemically administered nanoparticles.
Dongyu Chen (2017)
10.1021/cr200359p
Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy.
J. Yao (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar